Brand Reference: Livalo, Zypitamag
| Metric | Verified Benchmark | Source |
|---|---|---|
| Pitavastatin Calcium RxNorm Concept ID | 861634 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.6400 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $284.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $14.20 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $17.00 / mo | 23 Zero-PHI Verified Patient Logs |
Cyclopropyl-substituted statin engineered for minimal muscle lactone penetration and near-zero diabetogenic HbA1c drift, lowering ApoB by 32%–43% while modestly raising ApoA1/HDL-C without CYP3A4 substrate liability.
Across 23 community cost disclosures for Pitavastatin Calcium (Livalo / Zypitamag), cash buyers routing around $284.00 retail markups capture a 95% discount ($14.20/mo benchmark vs $0.6400 NADAC acquisition).
Following administration (1 mg PO once daily), Pitavastatin Calcium achieves 51% oral bioavailability and 2–4 weeks lipid steady state onset, governed by a 12 hours terminal half-life through enterohepatic circulation with ugt1a3/ugt2b7 lactonization; negligible cyp2c9.
Before initiating Pitavastatin Calcium at 1 mg PO once daily, clinical safety checklists rule out cyclosporine co-administration; active hepatic cholestasis. Logged tolerability patterns center on back discomfort (4% of reports), myalgia (3% of reports), constipation (3% of reports).
Across 23 verified cash-pay logs, Pitavastatin Calcium achieves a 93.10% Worth-It rating with out-of-pocket spend averaging $17.00/mo versus $284.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 1 mg PO once daily for Pitavastatin Calcium; monthly out-of-pocket dropped to $12.50 compared with $284.00 retail.
Completed 10 weeks on Pitavastatin Calcium (2 mg PO once daily). Zero notable side effects on steady dosing.
Consistent biomarker response on 4 mg PO once daily Pitavastatin Calcium sourced via Compounding ($16.47/mo cash pay without insurance prior authorization).